Ascentage Pharma Group International has filed a next day disclosure return with the Hong Kong Stock Exchange, announcing the issuance of 22,000,000 new ordinary shares. These shares were allotted at a subscription price of HK$68.6 per share, resulting in a 6.3037% increase in the total number of issued shares. The filing was submitted on July 25, 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.